Ziccum’s unique LaminarPace technology transforms delicate liquid biotherapeutics into robust, thermostable, and high-yield dry powders without exposing them to extreme temperatures, stress, or degradation. This innovative approach ensures the preservation, and even enhancement, of mRNA drug activity in dried materials.
Join Ziccum at the Future of Swedish & Danish Life Science event in Lund on August 29th. Meet with COO Xavier Turon to discover how LaminarPace is setting new standards in biotherapeutic formulation and learn more about its potential to revolutionize mRNA-based treatments.
Book a meeting here: https://ziccum.com/about-us/contact/